Stevanato (STVN) Financial Analysis & Valuation | Quarter Chart
Stevanato (STVN)
STVNPrice: $17.85
Fair Value: 🔒
🔒score
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspec... more
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes... more
Description
Shares
| Market Cap | $4.87B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | IT | CEO | Franco Stevanato |
| IPO Date | 2021-07-16 | CAGR | 0.16% |
| Employees | 5,521 | Website | www.stevanatogroup.com |
| Div. Yield | 0.34% | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | 0.34% |
STVN chart loading...
Fundamentals
Technicals
| Enterprise Value | $4.73B | P/E Ratio | 30.25 |
| Forward P/E | 21.19 | PEG Ratio | 10.53 |
| P/S Ratio | 3.6 | P/B Ratio | 2.98 |
| P/CF Ratio | 18.19 | P/FCF Ratio | 287.57 |
| EPS | $0.59 | EPS Growth 1Y | 21.84% |
| EPS Growth 3Y | -1.89% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 6.98% | Gross Margin | 0.29% |
| Operating Margin | 0.17% | Profit Margin | 0.12% |
| ROE | 0.1% | ROA | 0.06% |
| ROCE | 0.1% | Current Ratio | 1.89 |
| Quick Ratio | 1.3 | Cash Ratio | 0.24 |
| Debt/Equity | 0.32 | Interest Coverage | 32.12 |
| Altman Z Score | 3.94 | Piotroski Score | 6 |